Results 21 to 30 of about 67,043 (290)

The Relationship between Severity of Lung Involvement Based on High-Resolution Computed Tomography (HRCT) Findings and Lymphopenia in Patients with COVID-19 [PDF]

open access: yesDisease and Diagnosis, 2022
Background: Lymphopenia may reflect the degree of lung injury in patients with coronavirus disease 2019 (COVID-19). Given that few studies have been conducted in this regard, this study aimed to evaluate the association between severity of lung ...
Abolfazl Izadi   +6 more
doaj   +1 more source

Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study

open access: yesArchives of Medical Science, 2020
Introduction Several reports have noted that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induced lymphopenia in coronavirus disease 2019 (COVID-19) patients. However, the clinical significance of lymphopenia remains unclear.
Jun Fei   +8 more
doaj   +1 more source

Prognostic Value and Risk Factors of Treatment-Related Lymphopenia in Malignant Glioma Patients Treated With Chemoradiotherapy: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Neurology, 2022
Background: Immunotherapy has shown promising therapeutic efficacy in various cancers but not gliomas. Circulating lymphocytes play critical roles in cancer control and responses to immune checkpoint inhibitors.
Yongchao Zhang   +6 more
doaj   +1 more source

Persisting lymphopenia and dimethyl fumarate: A clinical commentary.

open access: yes, 2021
Severe prolonged lymphopenia as rare side-effect of dimethyl fumarate is mostly reversible. Caldito et al. report a case of persistent severe lymphopenia over 5 years after discontinuation of dimethyl fumarate.
Chan, Andrew, Diem, Lara
core   +1 more source

Lymphopenia: A predictive marker of disease severity in COVID-19 infection [PDF]

open access: yesRomanian Journal of Medical Practice, 2021
Background. With the latest COVID-19 deaths reported to WHO now exceeding 3.3 million, COVID-19 has developed into a milestone of our medical generation, causing disruption in communities and hospital services.
Georgeta Daniela Georgescu   +10 more
doaj   +1 more source

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients

open access: yesFrontiers in Oncology, 2022
BackgroundTo evaluate longitudinal changes of concurrent chemoradiotherapy (CCRT) related lymphopenia and its association with survival in locally advanced non-small cell lung cancer (LA-NSCLC) patients.MethodsTotal lymphocyte count (TLC) at baseline ...
FangJie Liu   +21 more
doaj   +1 more source

Pooled prevalence of lymphopenia in all-cause hospitalisations and association with infection: a systematic review and meta-analysis

open access: yesBMC Infectious Diseases, 2023
Background Lymphopenia is defined as a decrease below normal value (often 1.0 x 109 cells/L) of blood circulating lymphocyte count. In the general population, lymphopenia is associated with an increased risk of hospitalisation secondary to infection ...
ZC Elçioğlu   +7 more
doaj   +1 more source

Limfopenia dan Rasio Neutrofil-Limfosit pada Infeksi Severe Acute Respiratory Syndrome Coronavirus 2

open access: yesJurnal Kesehatan Andalas, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause cytokine storm characterized by the excessive release of pro-inflammatory cytokines, leading to lymphopenia and neutrophilia.
Hevrina Yufani   +2 more
doaj   +1 more source

Neoadjuvant chemoradiotherapy induced lymphopenia in gastric cancer and associations with spleen dosimetry and survival outcomes

open access: yesClinical and Translational Radiation Oncology, 2023
Background: Few studies concentrate on spleen dosimetry of radiotherapy for gastric cancer (GC). Although there is no consensus on the spleen dose-volume threshold for lymphopenia, several studies indicated that the higher the spleen dose, the higher the
Ji-jin Wang   +7 more
doaj   +1 more source

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer [PDF]

open access: yesJournal of Immunotherapy and Precision Oncology, 2023
Introduction: We aimed to identify clinical, pathologic, and treatment factors that are predictive of response and survival in patients with cervical cancer referred to phase I clinical trials. Methods: Patients with cervical cancer who received at least
Ji Son   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy